Trial
NCT02296346
Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
Mallinckrodt
Condition
Secondary Progressive Multiple Sclerosis
Intervention
SoluMedrol
Why stopped
Low enrollment/PI relocated. New site couldn't reach agreement with manufacturer
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-14